$PGNX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in PROGENICS PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in PROGENICS PHARMACEUTICALS INC. Get notifications about new insider transactions in PROGENICS PHARMACEUTICALS INC for free.

Page:   < prev 1 ... 7 8 9 10 11 12 13 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 05 2006PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseA25.0180620,158806
Jan 05 2006PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseM20.863677,6560
Jan 05 2006PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Payment of ExerciseF25.843248,37220,43020.8 K to 20.4 K (-1.56 %)
Jan 05 2006PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...BuyM20.863677,65620,75420.4 K to 20.8 K (+1.80 %)
Jan 05 2006PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...Option ExerciseA25.012,34158,5482,341
Jan 05 2006PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...Option ExerciseM20.861,60833,5430
Jan 05 2006PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...Payment of ExerciseF25.841,42236,744586,615588 K to 586.6 K (-0.24 %)
Jan 05 2006PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...BuyM20.861,60833,543588,037586.4 K to 588 K (+0.27 %)
Jan 05 2006PGNXPROGENICS PHARMACE ...Baker Mark RobertGeneral CounselOption ExerciseA25.011,44936,2391,449
Jan 05 2006PGNXPROGENICS PHARMACE ...Baker Mark RobertGeneral CounselOption ExerciseM20.8653911,2440
Jan 05 2006PGNXPROGENICS PHARMACE ...Baker Mark RobertGeneral CounselPayment of ExerciseF25.8447712,3262,3162.8 K to 2.3 K (-17.08 %)
Jan 05 2006PGNXPROGENICS PHARMACE ...Baker Mark RobertGeneral CounselBuyM20.8653911,2442,7932.3 K to 2.8 K (+23.91 %)
Jan 05 2006PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseA25.0182520,633825
Jan 05 2006PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseM20.863908,1350
Jan 05 2006PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Payment of ExerciseF25.843448,88918,67019 K to 18.7 K (-1.81 %)
Jan 05 2006PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...BuyM20.863908,13519,01418.6 K to 19 K (+2.09 %)
Jan 05 2006PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseA25.011,03025,7601,030
Jan 05 2006PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseM20.8663513,2460
Jan 05 2006PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...BuyM20.8663513,24620,62820 K to 20.6 K (+3.18 %)
Jan 05 2006PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Payment of ExerciseF24.8456113,93519,99320.6 K to 20 K (-2.73 %)
Dec 20 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseM4.008,75035,00010,000
Dec 20 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...SellS22.388,750195,84320,49629.2 K to 20.5 K (-29.92 %)
Dec 20 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...BuyM4.008,75035,00029,24620.5 K to 29.2 K (+42.69 %)
Dec 12 2005PGNXPROGENICS PHARMACE ...BRINER KURT WDirectorOption ExerciseA24.1225,000603,00025,000
Dec 12 2005PGNXPROGENICS PHARMACE ...JACOBSON PAUL FDirectorOption ExerciseA24.1225,000603,00025,000
Oct 05 2005PGNXPROGENICS PHARMACE ...Kremer Alton BVP, Clinical Resear ...Option ExerciseA23.7158013,752580
Oct 05 2005PGNXPROGENICS PHARMACE ...Kremer Alton BVP, Clinical Resear ...Option ExerciseM16.8181813,7510
Oct 05 2005PGNXPROGENICS PHARMACE ...Kremer Alton BVP, Clinical Resear ...Payment of ExerciseF24.6766216,3326,8327.5 K to 6.8 K (-8.83 %)
Oct 05 2005PGNXPROGENICS PHARMACE ...Kremer Alton BVP, Clinical Resear ...BuyM16.8181813,7517,4946.7 K to 7.5 K (+12.25 %)
Oct 05 2005PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseA23.713237,658323
Oct 05 2005PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseM16.813586,0180
Oct 05 2005PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Payment of ExerciseF24.672907,15420,32920.6 K to 20.3 K (-1.41 %)
Oct 05 2005PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...BuyM16.813586,01820,61920.3 K to 20.6 K (+1.77 %)
Oct 05 2005PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Option ExerciseA23.712906,876290
Oct 05 2005PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Option ExerciseM16.814096,8750
Oct 05 2005PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Payment of ExerciseF24.673318,16618,03818.4 K to 18 K (-1.80 %)
Oct 05 2005PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...BuyM16.814096,87518,36918 K to 18.4 K (+2.28 %)
Oct 05 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...Option ExerciseA23.711,41533,5501,415
Oct 05 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...Option ExerciseM16.811,99633,5530
Oct 05 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...Payment of ExerciseF24.671,61439,817586,429588 K to 586.4 K (-0.27 %)
Oct 05 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...BuyM16.811,99633,553588,043586 K to 588 K (+0.34 %)
Oct 05 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseA23.7155913,254559
Oct 05 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseM16.8178813,2460
Oct 05 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Payment of ExerciseF24.6763715,71520,49621.1 K to 20.5 K (-3.01 %)
Oct 05 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...BuyM16.8178813,24621,13320.3 K to 21.1 K (+3.87 %)
Oct 05 2005PGNXPROGENICS PHARMACE ...Baker Mark RobertGeneral CounselOption ExerciseA23.7147411,239474
Oct 05 2005PGNXPROGENICS PHARMACE ...Baker Mark RobertGeneral CounselGrantA24.6770917,4912,1961.5 K to 2.2 K (+47.68 %)
Oct 05 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseA23.713438,133343
Oct 05 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseM16.814838,1190
Oct 05 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Payment of ExerciseF24.673919,64618,56619 K to 18.6 K (-2.06 %)
Oct 05 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...BuyM16.814838,11918,95718.5 K to 19 K (+2.61 %)
Sep 14 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...SellS25.003,00075,00020,15523.2 K to 20.2 K (-12.96 %)
Sep 14 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...SellS25.002,00050,00023,15525.2 K to 23.2 K (-7.95 %)
Aug 03 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseM4.002,0008,0000
Aug 03 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseM4.004,00016,0002,000
Aug 03 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseM4.004,00016,0006,000
Aug 03 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseM4.002,0008,00010,000
Aug 03 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...SellS23.352,00046,70018,28420.3 K to 18.3 K (-9.86 %)
Aug 03 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...BuyM4.002,0008,00020,28418.3 K to 20.3 K (+10.94 %)
Aug 03 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...SellS23.404,00093,60018,28422.3 K to 18.3 K (-17.95 %)
Aug 03 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...BuyM4.004,00016,00022,28418.3 K to 22.3 K (+21.88 %)
Aug 03 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...SellS23.454,00093,80018,28422.3 K to 18.3 K (-17.95 %)
Aug 03 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...BuyM4.004,00016,00022,28418.3 K to 22.3 K (+21.88 %)
Aug 03 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...SellS23.502,00047,00018,28420.3 K to 18.3 K (-9.86 %)
Aug 03 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...BuyM4.002,0008,00020,28418.3 K to 20.3 K (+10.94 %)
Jul 13 2005PGNXPROGENICS PHARMACE ...SCHEINBERG DAVID ADirectorOption ExerciseM4.002,0008,00063,000
Jul 13 2005PGNXPROGENICS PHARMACE ...SCHEINBERG DAVID ADirectorGiftG0.00468024,18123.7 K to 24.2 K (+1.97 %)
Jul 13 2005PGNXPROGENICS PHARMACE ...SCHEINBERG DAVID ADirectorSellM23.002,00046,00023,71325.7 K to 23.7 K (-7.78 %)
Jul 13 2005PGNXPROGENICS PHARMACE ...SCHEINBERG DAVID ADirectorBuyM4.002,0008,00025,71323.7 K to 25.7 K (+8.43 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...SCHEINBERG DAVID ADirectorOption ExerciseA21.397,500160,42517,500
Jul 06 2005PGNXPROGENICS PHARMACE ...SCHEINBERG DAVID ADirectorOption ExerciseA21.3910,000213,90010,000
Jul 06 2005PGNXPROGENICS PHARMACE ...SCHEINBERG DAVID ADirectorOption ExerciseM4.002,0008,00065,000
Jul 06 2005PGNXPROGENICS PHARMACE ...SCHEINBERG DAVID ADirectorSellS20.852,00041,70023,71325.7 K to 23.7 K (-7.78 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...SCHEINBERG DAVID ADirectorBuyM4.002,0008,00025,71323.7 K to 25.7 K (+8.43 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...Baker Mark RobertGeneral CounselOption ExerciseA20.0250,0001,001,00050,000
Jul 06 2005PGNXPROGENICS PHARMACE ...Baker Mark RobertGeneral CounselGrantA17.7398717,5001,487500 to 1.5 K (+197.40 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Option ExerciseA21.3912,500267,37512,500
Jul 06 2005PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...Option ExerciseA20.863296,863329
Jul 06 2005PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...GrantA0.004,500017,77013.3 K to 17.8 K (+33.91 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...Olson William CVP, Research & Deve ...GrantA17.161592,72813,27013.1 K to 13.3 K (+1.21 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...Kremer Alton BVP, Clinical Resear ...Option ExerciseA21.3910,000213,90010,000
Jul 06 2005PGNXPROGENICS PHARMACE ...Kremer Alton BVP, Clinical Resear ...Option ExerciseA20.8665913,747659
Jul 06 2005PGNXPROGENICS PHARMACE ...Kremer Alton BVP, Clinical Resear ...GrantA0.003,50006,4863 K to 6.5 K (+117.21 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...Kremer Alton BVP, Clinical Resear ...GrantA17.161873,2092,9862.8 K to 3 K (+6.68 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseA21.3910,000213,90010,000
Jul 06 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...Option ExerciseA20.8663513,246635
Jul 06 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...GrantA17.161783,05425,15525 K to 25.2 K (+0.71 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSr. VP, Medical Aff ...GrantA0.003,500024,97721.5 K to 25 K (+16.30 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...Option ExerciseA21.3975,0001,604,25075,000
Jul 06 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...Option ExerciseA20.861,30827,2851,308
Jul 06 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...GrantA0.0025,0000586,047561 K to 586 K (+4.46 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JChief Executive Off ...GrantA17.164928,443561,047560.6 K to 561 K (+0.09 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseA21.3925,000534,75025,000
Jul 06 2005PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...Option ExerciseA20.862886,008288
Jul 06 2005PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...GrantA0.007,500020,07112.6 K to 20.1 K (+59.66 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...Boyd Thomas ASr. VP, Product Dev ...GrantA17.161452,48812,57112.4 K to 12.6 K (+1.17 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseA21.3912,500267,37512,500
Jul 06 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...Option ExerciseA20.863898,115389
Jul 06 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...GrantA0.004,500018,28413.8 K to 18.3 K (+32.65 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AChief Financial Off ...GrantA17.161592,72813,78413.6 K to 13.8 K (+1.17 %)
Jul 06 2005PGNXPROGENICS PHARMACE ...BAKER CHARLES ADirectorOption ExerciseA21.3910,000213,90010,000
Jul 06 2005PGNXPROGENICS PHARMACE ...GOFF STEPHEN PDirectorOption ExerciseA21.3910,000213,90010,000
Jul 06 2005PGNXPROGENICS PHARMACE ...DALTON MARK FDirectorOption ExerciseA21.3910,000213,90010,000
Jun 22 2005PGNXPROGENICS PHARMACE ...Boyd Thomas ASR. VP, Product Dev ...SellS19.8575014,88812,42613.2 K to 12.4 K (-5.69 %)
Jun 22 2005PGNXPROGENICS PHARMACE ...Olson William CVP, Research and De ...SellS20.0065013,00013,11113.8 K to 13.1 K (-4.72 %)
Jun 22 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JCEO & CSOSellS20.053,25065,163599,303602.6 K to 599.3 K (-0.54 %)
Jun 22 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JCEO & CSOSellS20.003,00060,000602,553605.6 K to 602.6 K (-0.50 %)
Jun 22 2005PGNXPROGENICS PHARMACE ...JACOBSON PAUL FDirectorSellS19.853,00059,550188,100191.1 K to 188.1 K (-1.57 %)
Jun 22 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSR. VP Medical Affa ...SellS19.8775014,90321,47722.2 K to 21.5 K (-3.37 %)
Jun 22 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT ACheif Financial Off ...SellS19.8775014,90313,62514.4 K to 13.6 K (-5.22 %)
Jun 22 2005PGNXPROGENICS PHARMACE ...GOFF STEPHEN PDirectorSellS19.853,00059,55033,50036.5 K to 33.5 K (-8.22 %)
Apr 05 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AV.P., Finance & Ope ...Option ExerciseA16.811,37623,1311,376
Apr 05 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AV.P., Finance & Ope ...GrantA13.604054414,37514.3 K to 14.4 K (+0.28 %)
Apr 05 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JCEO & CSOOption ExerciseA16.814,22771,0564,227
Apr 05 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JCEO & CSOGrantA13.602032,761566,805566.6 K to 566.8 K (+0.04 %)
Apr 05 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSenior V.P., Medica ...Option ExerciseA16.811,53225,7531,532
Apr 05 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSenior V.P., Medica ...GrantA13.60801,08822,22722.1 K to 22.2 K (+0.36 %)
Mar 03 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AVice President, Fin ...Option ExerciseA22.6825,000567,00025,000
Feb 28 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AVice President, Fin ...Option ExerciseM4.003,00012,00012,000
Feb 28 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AVice President, Fin ...SellS24.003,00072,00014,27117.3 K to 14.3 K (-17.37 %)
Feb 28 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AVice President, Fin ...BuyM4.003,00012,00017,27114.3 K to 17.3 K (+21.02 %)
Feb 17 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AV.P., Finance & Ope ...Option ExerciseA17.161,34823,1321,348
Feb 17 2005PGNXPROGENICS PHARMACE ...MCKINNEY ROBERT AV.P., Finance & Ope ...BuyM16.794473914,27114.2 K to 14.3 K (+0.31 %)
Feb 17 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSenior Vice Preside ...Option ExerciseA17.161,50125,7571,501
Feb 17 2005PGNXPROGENICS PHARMACE ...ISRAEL ROBERT JSenior Vice Preside ...BuyM16.79821,37722,08322 K to 22.1 K (+0.37 %)
Feb 17 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JCEO & CSOOption ExerciseA17.164,06169,6874,061
Feb 17 2005PGNXPROGENICS PHARMACE ...MADDON PAUL JCEO & CSOBuyM16.792003,358541,602541.4 K to 541.6 K (+0.04 %)
Feb 17 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentOption ExerciseA17.162,13336,6022,133
Feb 17 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentBuyM16.791101,84733,53933.4 K to 33.5 K (+0.33 %)
Feb 07 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentOption ExerciseM9.258,00074,00048,800
Feb 07 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentOption ExerciseM9.2518,000166,50056,800
Feb 07 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentSellS21.008,000168,00033,57841.6 K to 33.6 K (-19.24 %)
Feb 07 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentBuyM9.258,00074,00041,57833.6 K to 41.6 K (+23.83 %)
Feb 07 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentSellS21.206,000127,20033,57839.6 K to 33.6 K (-15.16 %)
Feb 07 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentSellS21.156,000126,90039,57845.6 K to 39.6 K (-13.16 %)
Feb 07 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentSellS21.122,00042,24045,57847.6 K to 45.6 K (-4.20 %)
Feb 07 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentSellS21.004,00084,00047,57851.6 K to 47.6 K (-7.76 %)
Feb 07 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentBuyM9.2518,000166,50051,57833.6 K to 51.6 K (+53.61 %)
Feb 03 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentOption ExerciseM9.2511,000101,75074,800
Feb 03 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentOption ExerciseM9.256,00055,50085,800
Feb 03 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentSellS20.601,00020,60033,57834.6 K to 33.6 K (-2.89 %)
Feb 03 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentSellS20.5010,000205,00034,57844.6 K to 34.6 K (-22.43 %)
Feb 03 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentBuyM9.2511,000101,75044,57833.6 K to 44.6 K (+32.76 %)
Feb 03 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentSellS20.001,00020,00033,57834.6 K to 33.6 K (-2.89 %)
Feb 03 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentSellS20.151,00020,15034,57835.6 K to 34.6 K (-2.81 %)
Feb 03 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentSellS20.102,00040,20035,57837.6 K to 35.6 K (-5.32 %)
Feb 03 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentSellS20.201,00020,20037,57838.6 K to 37.6 K (-2.59 %)
Feb 03 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentSellS20.251,00020,25038,57839.6 K to 38.6 K (-2.53 %)
Feb 03 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentBuyM9.256,00055,50039,57833.6 K to 39.6 K (+17.87 %)
Feb 01 2005PGNXPROGENICS PHARMACE ...PRENTKI RONALD JPresidentOption ExerciseM9.2523,000212,75091,800

Page:   < prev 1 ... 7 8 9 10 11 12 13 next >

Contact us | Follow us on Twitter